Related Experiment Video

Updated: Jun 1, 2026

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

Oligomerization and toxicity of Aβ fusion proteins

Joanne M Caine1, Prashant R Bharadwaj, Sonia E Sankovich

  • 1CSIRO Materials Science and Engineering and the Preventive Health Flagship, Parkville, Victoria, Australia. Jo.Caine@csiro.au

Biochemical and Biophysical Research Communications
|May 24, 2011
PubMed

Insights

Maltose binding protein Aβ42 (MBP-Aβ42) fusion protein forms toxic soluble oligomers, unlike shorter versions. This finding supports MBP-Aβ42's utility in drug screening assays and Alzheimer's disease research.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Cell Biology

Background:

  • Amyloid-beta (Aβ) peptides, particularly Aβ42, are implicated in Alzheimer's disease pathogenesis.
  • Oligomeric forms of Aβ are considered highly neurotoxic.
  • Developing reliable reagents for studying Aβ toxicity is crucial for Alzheimer's research.

Purpose of the Study:

  • To investigate the oligomerization and toxicity of Maltose binding protein Aβ42 (MBP-Aβ42) fusion protein.
  • To compare the properties of MBP-Aβ42 with a shorter fusion protein (MBP-Aβ16) and control Maltose binding protein (MBP).
  • To assess the potential of MBP-Aβ42 as a tool for drug discovery and Aβ42 characterization.

Main Methods:

  • Construction and expression of MBP-Aβ42 and MBP-Aβ16 fusion proteins.
  • Analysis of protein oligomerization in solution.
  • Dose-dependent toxicity assays in yeast and primary cortical neuronal cells.

Main Results:

  • MBP-Aβ42 formed soluble oligomers, while MBP-Aβ16 and MBP did not.
  • MBP-Aβ42 exhibited dose-dependent toxicity in both yeast and neuronal cell models.
  • MBP-Aβ16 and control MBP showed no significant toxicity.

Conclusions:

  • MBP-Aβ42 is a valuable tool for generating toxic Aβ species.
  • The study validates MBP-Aβ42 as a potential reagent for high-throughput drug screening in cellular models.
  • MBP-Aβ42 serves as a promising candidate for further investigation into Aβ42-related mechanisms.

More Related Videos

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...